HUMANS' MICROBIOME IMPACT ON DISEASE

Authors

  • Bhim Singh Guru Kashi University, Talwandi Sabo Author
  • Rajesh Kumar Guru Kashi University, Talwandi Sabo Author

DOI:

https://doi.org/10.61841/r9ftkm32

Keywords:

Microbiome, Health, Infectious disease, Liver diseases, Human

Abstract

Hundreds of billions of microbes have coexisted with humans and now live on and within them. Microbial imbalance in the intestine is regulated by a variety of factors, and it has a strong link to human health and disease. The human microbiome is made up of bacteria, archaea, viruses, and eukaryotes that exist both within and outside our bodies. In both health and illness, these organisms have an impact on human physiology, promoting or inhibiting metabolic and immunological processes. Microorganisms' colonize a wide range of sites on and inside the human body, adapting to the niche's particular properties. As a result of their biological interaction with the immune system throughout time, the indigenous organisms in the human body have become highly adapted to the immune system. The precise metabolic activities and functions of these microorganisms within each bodily location are accounted for by the inherent diversity of the human microbiota. As a result, it's critical to comprehend the human microbiome's microbial composition and behaviors as they relate to health and disease.

 

 

Downloads

Download data is not yet available.

References

[1]. L.K. Ursell, H.J. Haiser, W. Van Treuren, N. Garg, L. Reddivari, J. Vanamala, et

.The intestinal metabolome: an intersection between microbiota and host

Gastroenterology, 146 (6) (2014), pp. 1470-1476

[2]. W.B. Whitman, D.C. Coleman, W.J. Wiebe Prokaryotes: the unseen majority Proc

Natl Acad Sci USA, 95 (12) (1998), pp. 6578-6583

[3]. D.C. Savage Microbial ecology of the gastrointestinal tract Annu Rev Microbiol, 31

(1) (1977), pp. 107-133 CrossRefView Record in ScopusGoogle Scholar

[4]. R.E. Ley, D.A. Peterson, J.I. Gordon Ecological and evolutionary forces shaping

microbial diversity in the human intestine Cell, 124 (4) (2006), pp. 837-848

[5]. B. Wang, L. Li Who determines the outcomes of HBV exposure? Trends Microbiol,

23 (6) (2015), pp. 328-329

[6]. R.E. Ley, P.J. Turnbaugh, S. Klein, J.I. Gordon Microbial ecology: human gut

microbes associated with obesity Nature, 444 (7122) (2006), pp. 1022-1023 CrossRefView

Record in ScopusGoogle Scholar

[7]. B. Wang, X. Jiang, M. Cao, J. Ge, Q. Bao, L. Tang, et al. Altered fecal microbiota

correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver

disease Sci Rep, 6 (2016), Article 32002

[8]. S.R. Gill, M. Pop, R.T. Deboy, P.B. Eckburg, P.J. Turnbaugh, B.S. Samuel, et al.

Metagenomic analysis of the human distal gut microbiome Science, 312 (5778) (2006), pp.

1355-1359

[9]. M.B. Roberfroid, F. Bornet, C. Bouley, J.H. Cummings Colonic microflora:

nutrition and health. Summary and conclusions of an International Life Sciences Institute

(ILSI) [Europe] workshop held in Barcelona, Spain Nutr Rev, 53 (5) (1995), pp. 127-130

[10]. H.L. Cash, C.V. Whitham, C.L. Behrendt, L.V. Hooper Symbiotic bacteria direct

expression of an intestinal bactericidal lectin Science, 313 (5790) (2006), pp. 1126-1130

[11]. L.V. Hooper, T.S. Stappenbeck, C.V. Hong, J.I. Gordon Angiogenins: a new class

of microbicidal proteins involved in innate immunity Nat Immunol, 4 (3) (2003), pp. 269-

273

[12]. J. Schauber, C. Svanholm, S. Termén, K. Iffland, T. Menzel, W. Scheppach, et al.

Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes:

relevance of signalling pathways Gut, 52 (5) (2003), pp. 735-741

[13]. D. Bouskra, C. Brézillon, M. Bérard, C. Werts, R. Varona, I.G. Boneca, et al.

Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal

homeostasis Nature, 456 (7221) (2008), pp. 507-510

[14]. S. Rakoff-Nahoum, R. Medzhitov Innate immune recognition of the indigenous

microbial flora Mucosal Immunol, 1 (Suppl 1) (2008), pp. S10-S14

[15]. A.J. Macpherson, N.L. Harris Interactions between commensal intestinal bacteria

and the immune system Nat Rev Immunol, 4 (6) (2004), pp. 478-485

I. Sekirov, S.L. Russell, L.C. Antunes, B.B. Finlay Gut microbiota in health and

disease Physiol Rev, 90 (3) (2010), pp. 859-904

[16]. R.B. Sartor Microbial influences in inflammatory bowel diseases Gastroenterology,

134 (2) (2008), pp. 577-594

[17]. Q. Liu, Z. Duan, D. Ha, S. Bengmark, J. Kurtovic, S.M. Riordan Synbiotic

modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

Hepatology, 39 (5) (2004), pp. 1441-1449

[18]. P.D. Scanlan, F. Shanahan, Y. Clune, J.K. Collins, G.C. O’Sullivan, M.O’Riordan,

et al. Culture-independent analysis of the gut microbiota in colorectal cancel and polyposis

Environ Microbiol, 10 (3) (2008), pp. 789-798

[19]. S.L. Verhulst, C. Vael, C. Beunckens, V. Nelen, H. Goossens, K. Desager A

longitudinal analysis on the association between antibiotic use, intestinal microflora, and

wheezing during the first year of life J Asthma, 45 (9) (2008), pp. 828-832

[20]. S.M. Finegold, D. Molitoris, Y. Song, C. Liu, M.L. Vaisanen, E. Bolte, et al.

Gastrointestinal microflora studies in late-onset autism Clin Infect Dis, 35 (Suppl 1) (2002),

pp. S6-S16

[21]. L. Wen, R.E. Ley, P.Y. Volchkov, P.B. Stranges, L. Avanesyan, A.C. Stonebraker,

et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes

Nature, 455 (7216) (2008), pp. 1109-1113

[22]. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, J.I.

Gordon

[23]. An obesity-associated gut microbiome with increased capacity for energy harvest

Downloads

Published

30.06.2021

How to Cite

Singh, B., & Kumar, R. (2021). HUMANS’ MICROBIOME IMPACT ON DISEASE. International Journal of Psychosocial Rehabilitation, 25(3), 1231-1240. https://doi.org/10.61841/r9ftkm32